Skip to content
Menu

HC Wainwright & Co. Maintains Buy on CG Oncology, Raises Price Target to $115

Benzinga Newsdesk 13 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

HC Wainwright & Co. analyst Andres Y. Maldonado maintains CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $100 to $115.

HC Wainwright & Co. analyst Andres Y. Maldonado maintains CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $100 to $115.

Read at benzinga.com